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Using a newly discovered encapsulin from Mycolicibacterium hassiacum, several biocatalysts were
packaged in this robust protein cage. The encapsulin was found to be easy to produce as recombinant
protein. Elucidation of its crystal structure revealed that it is a spherical protein cage of 60 protomers
(diameter of 23 nm) with narrow pores. By developing an effective coexpression and isolation procedure,
the effect of packaging a variety of biocatalysts could be evaluated. It was shown that encapsulation
results in a significantly higher stability of the biocatalysts. Most of the targeted cofactor-containing
biocatalysts remained active in the encapsulin. Due to the restricted diameters of the encapsulin pores
(5e9 Å), the protein cage protects the encapsulated enzymes from bulky compounds. The work shows
that encapsulins may be valuable tools to tune the properties of biocatalysts such as stability and sub-
strate specificity.
© 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Compartmentalization of the cell’s interior to create distinct
organelles is a defining hallmark of eukaryotes. This provides these
cells with a way to separate and optimize metabolic processes.
Although typical membrane-encompassed organelles are lacking,
bacteria have found other ways to compartmentalize enzymes by
using proteinaceous structures. While the reason for bringing
together a selected set of enzymes within a protein shell is not
always clear, bacterial microcompartments are conserved and
widespread in the bacterial kingdom [1,2]. This strongly suggests
that they are essential for proper functioning of the encapsulated
enzymes. This type of subcellular co-localization may be to facili-
tate substrate transfer between connected reactions and to shield
the separated metabolism from interference by other cellular
components. Moreover, encapsulation of enzymes within a protein
cage can promote the reaction rate as a consequence of the highBiology of Viruses, Heinrich-
ologie - Centre for Structural
ermany.
r Inc. This is an open access articleffective concentration of enzyme, which leads to rapid formation
of the enzymeesubstrate complex [3,4]. Experimental work done
on the different bacterial protein-based compartments has
revealed that the selective incorporation of target proteins depends
on N- or C-terminal recognition peptides [5,6]. This is similar to
protein targeting in eukaryotic organelles, such as the N- or C-
terminal peroxisomal targeting sequences [7]. Bacterial micro-
compartments are normally larger (50e200 nm) and composed of
several building proteins while encapsulins are much smaller and
composed of only one protein.
Only about a decade ago a newly recognized class of bacterial
protein-based nanocompartments was described [8]. These so-
called encapsulins are formed by self-assembly of 60 or 180 iden-
tical encapsulin protomers to form cages with a diameter of roughly
24 or 32 nm, which are divided into four families [2]. In Nature,
these bacterial protein cages typically contain one or a few different
proteins, often enzymes. The encapsulated proteins are targeted to
the interior of encapsulins by virtue of a N- or C-terminal targeting
peptide. The rationale for the translocation of specific proteins into
encapsulins is still enigmatic. In most cases, encapsulins contain a
ferritin-like protein or a dye-decolorizing peroxidase (DyP), while
in some other cases other metal-containing proteins have been
identified [9]. A general feature of the cargo proteins seems to be ane under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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pothesized that encapsulins play a role in detoxification processes.
Several viral nanoparticles and bacterial microcompartments
have been produced as recombinant proteins and have been
studied with various cargo proteins in the context of fundamental
science, nanotechnology or as a tool in cell biology [9e17]. Exam-
ples of benefits of encapsulation are the encapsulation of a hy-
drogenase and multiple enzymes in bacteriophage capsids which
improved the stability of the respective enzymes [18,19]. It has also
been shown that foreign proteins can be targeted to encapsulins
[20]. This served as starting point to explore the value of these
protein cages for biocatalysis. In this work, we describe the struc-
tural features of an encapsulin originating from the meso-
thermophile Mycolicibacterium hassiacum (EncMh) and its use as
protein cage for several biocatalysts. Except for establishing a
highly effective production procedure for this robust encapsulin,
we elucidated its structure by cryo-electron microscopy and X-ray
crystallography. Furthermore, we demonstrate that various en-
zymes can be packaged in EncMh and be used as highly stable
encapsulated biocatalysts.2. Materials and methods
Details on the materials and methods used can be found in the
Supporting Information.2.1. Strains, plasmids and co-expression vectors
Escherichia coli NEB10b was used for routine cloning and
expression of EncMh. The gene encoding EncMh (YP_289707.1) was
synthesized as codon optimized for E. coli by GeneScript. Expres-
sion of EncMh was performed using a pBAD vector. Genes of the
cargo proteins were cloned into the pENC vector in order to be
compatible with the pBAD vector. Cargo protein was expressed
with a N-terminal 6xHis-tag and the C-terminal targeting tag. For
co-expression, pBAD-EncMh and pENC-cargo were co-transformed
into E. coli BL21-AI (ThermoFisher).2.2. Expression and purification of encapsulin and cargo enzymes
Expression of encapsulin and cargo enzyme was initiated by
adding 1 mM IPTG and 0.2% arabinose. Cultures were then incu-
bated for 16e20 h at 30 C and then harvested using centrifugation
and sonicated on ice. After centrifugation, the cleared cell-free
extract was loaded on a Ni-Sepharose column to remove the
excess of cargo-enzyme. For precipitation of EncMh, flow-through
fractions were mixed on ice with equal volumes of 10% PEG-8000
solution, 50 mM TrisHCl pH 7.5, 2 M NaCl. If needed, polishing
was done using a Superdex 200 column with 50 mM TrisHCl at pH
7.5 and 150 mMNaCl. Encapsulin and encapsulin loaded with cargo
enzyme eluted in the void volume.Fig. 1. (Left) A typical micrograph of EncMh (scale bar: 100 nm). (Right) Four repre-
sentative class averages of particles: images are the average sum of 1299, 602, 559 and
218 particles (top to bottom).2.3. Proteolytic resistance of encapsulin
Purified encapsulin (10 mg/mL) was incubated for 16 h with
bovine trypsin and Proteinase K to study resistance to proteolytic
degradation. Trypsin from bovine pancreas (1 mg/mL) was in
50 mM acetate buffer, while Proteinase K from T. album (1 mg/mL)
was in 50 mM TrisHCl pH 8.0 with 10 mM CaCl2. Reactions con-
tained 50 mL of 10mg/mL EncMh, 400 mL TrisHCl pH 8,10mM CaCl2,
2 mM DTT and 50 mL of protease solution. Samples were incubated
at 37 C for 16 h and were then analyzed by SDS PAGE.2.4. Cryo-transmission electron microscopy and X-ray
crystallography
Details on structural analyses of EncMh can be found in the
Supporting Information. Figures were prepared with PyMOL [21]
and ESPript [22]. Atomic coordinates and experimental structure
factor amplitudes for EncMh have been deposited in the RCSB
Protein Data Bank and are accessible under entry code 6I9G.3. Results and discussion
3.1. Overall structure of the Mycolicibacterium hassiacum
encapsulin
M. hassiacum is an actinobacterium which tolerates tempera-
tures up to 65 C [23]. By analyzing its genome for encapsulin ho-
mologs we identified a small operon consisting of two genes
encoding a putative encapsulin (EncMh, WP_005630281.1) and a
putative DyP-type peroxidase (EKF22245.1). The putative encap-
sulin has a predicted molecular mass of 29 kDa and shares 34%
sequence identity with the encapsulin from Thermotoga maritima
[8]. The putative DyP carries a C-terminal sequence that resembles
the targeting sequence used for incorporation into encapsulins.
Based on these observations we decided to clone the gene encoding
for EncMh for expression in E. coli. Upon screening expression
conditions, we achieved a remarkably high expression level. SDS-
PAGE analysis revealed that most of the intracellular protein was
EncMh. While EncMh could be purified to homogeneity by column
chromatography (Fig. S1), we also developed a simple purification
protocol that merely depends on the selective precipitation of
EncMh by 5% PEG8000. Both purification procedures yield an
impressive amount of 1 g purified EncMh from 1 L growth medium,
making EncMh an interesting candidate for further studies. EncMh
was found to be resistant to proteolytic degradation by bovine
trypsin and proteinase K (Fig. S2), as reported for other encapsulins
[20]. Additionally, EncMh displays a high thermostability as the
oligomeric state was found to be stable up to 50 C (Fig. S3). As
expected for encapsulins, gelpermeation already suggested that
EncMh forms large oligomers. Cryo-electron microscopy analysis
revealed that EncMh forms large spherical structures with a
diameter of about 22 nm, which is in line with other reported data
on encapsulins with a T ¼ 1 symmetry [9]. By class averaging an
icosahedral architecture became apparent (Fig. 1). For a more
detailed structural analysis, we set out to crystallize EncMh. This
N. Loncar et al. / Biochemical and Biophysical Research Communications 529 (2020) 548e553550resulted in well-diffracting crystals and allowed us to determine a
high-resolution structure of EncMh. The 2.5 Å electron density map
showed continuous density for all residues (1e265) in all fifteen
chains (A-O) in the asymmetric unit and has an R/Rfree of 17.2/
21.1%. Data collection and phasing details are summarized in
Table S1. Five protein chains form a pentamer and the T ¼ 1
icosahedral capsid is composed of 12 pentameric EncMh oligomers
(Fig. 2). The unit cell contains two icosahedrons with a diameter of
23 nm and a thickness of the protein layer of 2.0e2.5 nm. These
data are perfectly in line with the CryoEM data. A comparison of
EncMh with other capsid proteins shows that it is most similar to
the encapsulin from T. maritima (PDB 3DKT) [8]with a RMSD value
of 1.8 Å on 251 Ca atoms. The EncMh monomer shows the HK97
fold, the principal fold of many capsids, and consists of a P-domain
(peripheral domain), A-domain (axial domain) and E-loop (exten-
sion loop) (Fig. S4) [24]. Its N-terminus is located on the inside of
the capsule while the C-terminus is on the outside. The P-domain
(residues 1e43, 77e135 and 220e254) is composed of a three-
stranded antiparallel b-sheet (b4-b11-b12) with on one side two
small and two long a-helices (a1-a4). A small F-loop (44e46) is
inserted after a2 and the E-loop (47e76) is inserted which consists
of a kinked two-stranded b-sheet (b2-b3) and is involved in the
two-fold interaction in EncMh (Fig. S4). Helix a4 contains a 9 res-
idue excursion; Gly122-Gly130, called the G-loop [24]. The A-
domain (residues 136e219 and 254e265) is composed of a mixed
five-stranded b-sheet (b5-b6-b9-b10-b13), called b-hinge, that
links the A- and P-domains of HK97-like proteins and is flanked by
three a-helices (a5-a7) [24]. Interestingly, Cys134, the ultimate
residue of a4, is involved in a disulfide bridge with Cys254, the
ultimate residue of b12 from the P-domain. This disulfide is not
observed in structures of known homologous encapsulins and may
contribute to the stability of EncMh.
The tip of the A-domain is involved in the icosahedral five-fold
axis (Fig. S5). At this axis an opening is present with a diameter of
8 Å diameter which is shaped by His187-Gly-Tyr189 together with
Arg197. One of the bound sulfate ions occupies the entrance to the
capsid at the five-fold axis while 5 sulfate ions are bound close to
the entrance. The three-fold axis is located near the N-terminus
where no clear pore can be identified. However, two additional
pores are present at the interface of two monomers, one with a
diameter of 9 Å and one with a diameter of 5 Å (Fig. S6). The pore
diameters are similar to the pores of carboxysomes and metab-
olosomes that contain pores with a diameter of 4e10 Å [25].Fig. 2. Crystal structure of EncMh (PDB:6I9G). Left: the 60-meric EncMh with three pen
interpretation of the references to color in this figure legend, the reader is referred to the3.2. Development of EncMh as protein encapsulation platform
Having a robust encapsulin at hand which can be easily
expressed and isolated, we explored EncMh as packaging protein
for biocatalysts. The generated encapsulated biocatalysts were
tested for beneficial effects exerted by being packaged in EncMh.
We have explored the encapsulation of biocatalysts from different
enzyme classes (catalases, monooxygenases, oxidases, and peroxi-
dases), containing different types of cofactors (heme, flavin and
copper), and of different sizes (up to 270 kDa) (Figs. S7eS11). For
targeting the enzymes to the interior of EncMh, a C-terminal 30
residues peptide (PPPLPDSEPDREIPADDGSLGIGSLKGTRS) was
added to each enzyme. This targeting peptide is used by the native
DyP of M. hassiacum. Co-expression of EncMh and each target
enzyme was accomplished by using a two-plasmid system (for
details on vector design see SI). Co-precipitation of EncMh with
cargo protein during PEG precipitation and co-elution upon gel-
permeation was taken as proof of successful loading of EncMh.
CryoEMwas used to verify that cargo protein had not aggregated on
the outside of EncMh (Fig. S12).
As initial test we examined whether a small heme-containing
protein, bacterial hemoglobin VsHb (WP_019959060.1), could be
packaged in EncMh by coexpressing both proteins. VsHb was
cloned with and without C-terminal targeting peptide resulting in
proteins of 21 kDa and 18 kDa, respectively. These two proteins
were individually coexpressed with EncMh. VsHb with the encap-
sulation tag could be clearly observed in the isolated red-colored
EncMh, while the VsHb without encapsulation tag did not copre-
cipitate with EncMh but ended up in the soluble fraction. This
demonstrates that the employed C-terminal tag is efficient in
loading EncMh with foreign cargo proteins (Fig. S4). Next, we
decided to test loading of EncMh with various enzymes.
3.3. Encapsulation of a peroxidase and laccase by EncMh
First, a bacterial peroxidase, DyP from Saccharomonospora vir-
idisDSM43017 (SviDyP), was successfully packaged in EncMh. This
peroxidase was recently shown to be active on various dyes and
showed potential in modifying lignin-containing biomass [26].
Purification included, except for PEG precipitation, an affinity
chromatography step to remove any traces of non-encapsulated
SviDyP. Both EncMH and SviDyP were well expressed as evi-
denced by SDS-PAGE analysis (Fig. S7). The obtained proteintameric units in yellow. Right: a pentamer with protomers in different colors. (For
Web version of this article.)
N. Loncar et al. / Biochemical and Biophysical Research Communications 529 (2020) 548e553 551sample contained only the two overexpressed proteins and dis-
played a clear red color due to the presence of the heme cofactor in
SviDyP. Gel permeation confirmed that the peroxidase had been
incorporated in the encapsulin. The packaged peroxidase was
found to be active on ABTS, a commonly used peroxidase substrate
[27]. Using ABTS as test substrate, we examined the effect of
encapsulation on the kinetic parameters of SviDyP (Fig. 3). Non-
encapsulated enzyme displayed a kcat of 24.5 ± 0.9 s1 and a Km
of 0.15 ± 0.02 mM while encapsulated SviDyP displayed a slightly
lower kcat (17.9 ± 1.9 s1) and higher Km (0.55 ± 0.1 mM). Whether
the packaging in EncMh has a stabilizing effect on the peroxidase
was tested by incubating the encapsulated enzyme and the free
enzyme at 40 C and monitoring peroxidase activity in time. This
revealed that the packaging in EncMh has a strongly stabilizing
effect (Fig. S13). While the unpackaged peroxidase lost its activity
within 30 min, the packaged peroxidase showed even an increase
in activity in the first few hours and only after 25 h the activity
decreased significantly (Fig. S13). The increase in activity upon
incubation at higher temperature of enzymes from (semi)ther-
mophiles has been observed before [28,29] and may suggest that
an optimal catalytically competent conformation is attained at a
higher temperature. The stabilizing effect of encapsulation may
also be due to a molecular crowding effect: the intense protein-
protein interactions in the capsule prevents irreversible unfold-
ing and aggregation of the cargo protein.
We also coexpressed a bacterial copper-containing oxidase, a
laccase, with EncMh. This resulted in an encapsulated laccase as
evidenced by the green appearance of the isolated encapsulin
preparation. Activity of the laccase in EncMh was verified using
syringaldazine (MW 360 g/mol). As the bacterial laccase is already
highly thermostable [30], we were not able to assess the effect of
encapsulation on thermostability.3.4. Loading of EncMh with a large catalase
To challenge the capacity of EncMh, we also coexpressed a
tetrameric heme-containing catalase of 270 kDa from Thermobifida
fusca (TfuCat) [31]. Encapsulation of TfuCat was successful as
indicated by the isolation of intensely brown-colored encapsulin.
The encapsulation of TfuCat shows that EncMh can accommodate
cargo proteins ranging from 17 kDa (VsHb) to relatively large cargo
proteins such as catalase. The packaged catalase retained activity
on hydrogen peroxide and was also able to oxidize catechol, as was
reported for the isolated enzyme [31]. Encapsulated TfuCat showed
similar behavior as SviDyP. Upon encapsulation, TfuCat displayed a
slightly lower catalytic efficiency (kcat/Km) when compared with
the non-encapsulated catalase (0.7 vs. 1.6  106 s1M1).Fig. 3. The effect of encapsulation on activity of SviDyP.3.5. Encapsulation of flavoenzymes by EncMh
The loading of flavoenzymes was tested as well. It was found to
be possible to package a prototypical Baeyer-Villiger mono-
oxygenase, cyclohexanone monooxygenase (CHMO) [32]. Encap-
sulated CHMO did not show activity towards cyclohexanone,
although CHMO has been packaged in a correctly folded state (FAD-
bound) as suggested by the yellow appearance. In this case it is
likely that NADPH, the coenzyme required for activity, is not able to
enter the interior of the encapsulin. Pores of ~10 Å should allow
passage of substrates of up to 800 g/mol [33]. Since the measured
size of the pore is 9 Å and the molecular mass of NADPH is 744 g/
mol it is likely that NADPH cannot pass through the pores. This
observation may also provide an additional raison d’être for
encapsulins: they function as molecular sieves for the enzymes that
are in the encapsulins, thereby preventing undesired reactions. In
contrast to CHMO, an encapsulated FAD-containing carbohydrate
oxidase, mChitO [34], was found to be active when packaged in
EncMh (Fig. S14). This oxidase accepts various oligosaccharides. All
tested oligosaccharides (cellobiose, maltotriose and cellotetraose)
were found to be oxidized, indicating that EncMh allows passage of
such hydrophilic molecules, where the highest molar weight is the
one of cellotetraose (667 g/mol), which fits within the expected
molecular weight cut-off [33]. Furthermore, as was observed for the
peroxidase, mChitO showed improved thermostability at 50 C by
retaining half of its initial activity after 4 h, while soluble, non-
encapsulated mChitO loses most of its activity within 1 h (Fig. 4).3.6. The use encapsulated peroxidase for the synthesis of lignin-like
polymers
The compartmentalization of enzymes within encapsulin offers
the possibility of tuning the substrate scope of the enzyme. The
effect of added selectivity of enzymes encapsulated in EncMh was
assessed by performing a cascade reaction involving SviDyP.
Recently, we reported on the use of eugenol as startingmaterial and
eugenol oxidase and peroxidase as biocatalysts for the production
of lignin-like material [35e37]. We tested the effect of using
encapsulated SviDyP on the characteristics of the formed lignin
oligomers. It was found that the packaged peroxidase can still
support formation of lignin-like material as revealed by the for-
mation of insoluble lignin-like oligomers. Interestingly, the end-
product contains a slightly different relative abundance of the
linkages as compared to the system where peroxidase is notFig. 4. The effect of encapsulation on stability of ChitO (X-axis for time of incubation at
50 C; Y-axis, activity relative to the starting enzyme preparation).
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ted in a lower abundance of dibenzodioxin, b-O-4, b-b and b-5
linkages, while promoting formation of a-O-4 linkages (Table S1).
In summary, the results demonstrate that EncMh can be used to
package all kinds of biocatalysts, including heme-, flavin- and
metalloenzymes of different sizes and oligomerization states.
Successful incorporation of cofactor containing enzymes shows
that the enzymes are incorporated in the encapsulin nanocage after
folding and cofactor incorporation. This is in line with the proposed
mechanism of cargo loading which relies on association of the C-
terminal cargo loading peptide to encapsulin protomers during the
self-assembly process. This work also shows that the approach of
coexpressing EncMh with a target protein provides a generic
method for producing encapsulins loaded with any desired protein.
While this concept has been shown in other studies, for example for
creating artificial organelles in yeast [38] or size-selective RNA
packaging and creation of artificial proteasomes [39,40], we now
demonstrate that encapsulin-packaged enzymes can be used as
biocatalysts. Through engineering of the encapsulin, it may also be
possible to tune the catalytic properties of the enzyme. Recently,
the groups of Lutz and Hilvert have shown that through modifying
the pores of encapsulins or other protein-based cages, such cages
attain specific permeation properties [34,39e41]. This concept of
adding an additional filtering layer around an enzyme may also
have been the evolutionary trigger for bacteria to evolve such
protein-based nanocages.
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